{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:41:40Z","timestamp":1769517700274,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015310","name":"Natural Science Foundation of Xinjiang","doi-asserted-by":"publisher","award":["2019D01C110"],"award-info":[{"award-number":["2019D01C110"]}],"id":[{"id":"10.13039\/501100015310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Based on the antibody typing classification, <jats:italic>Helicobacter pylori<\/jats:italic> infection can be divided into type I <jats:italic>H. pylori<\/jats:italic> infection and type II <jats:italic>H. pylori<\/jats:italic> infection. To observe the effects of different <jats:italic>H. pylori<\/jats:italic> infection types on the distribution of histopathological characteristics and the levels of three items of serum gastric function (PG I, PG II, G-17). 1175 cases from October 2018 to February 2020 were collected with ratio 1:2. All patients were performed with <jats:sup>14<\/jats:sup>C-Urea breath test (<jats:sup>14<\/jats:sup>C-UBT), <jats:italic>H. pylori<\/jats:italic> antibody typing classification, three items of serum gastric function detection, painless gastroscopy, pathological examination, etc. According to <jats:italic>H. pylori<\/jats:italic> antibody typing classification, patients were divided into three groups: type I <jats:italic>H. pylori<\/jats:italic> infection group, type II <jats:italic>H. pylori<\/jats:italic> infection group and control group. Significant difference existed among type I <jats:italic>H. pylori<\/jats:italic> infection group, type II <jats:italic>H. pylori<\/jats:italic> infection group and control group in inflammation and activity (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u2009165.43, 354.88, <jats:italic>P<\/jats:italic> all\u2009&lt;\u20090.01). The proportion of three groups in OLGA staging had statistic difference (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200967.99, <jats:italic>P<\/jats:italic> all\u2009&lt;\u20090.01); Compared with type II <jats:italic>H. pylori<\/jats:italic> infection group and control group, the level of pepsinogen I, pepsinogen II, gastrin17 in type I <jats:italic>H. pylori<\/jats:italic> infection group increased, and PG I\/PG II ratio (PG I\/PG II ratio, PGR) decreased, which was statistically significant (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200935.08, 166.24, 134.21, 141.19; <jats:italic>P<\/jats:italic> all\u2009&lt;\u20090.01). Type I <jats:italic>H. pylori<\/jats:italic> infection worsened the severity of gastric mucosal inflammation and activity. <jats:italic>H. pylori<\/jats:italic> infection was prone to induce atrophy of gastric mucosa, while type I <jats:italic>H. pylori<\/jats:italic> infection played a key role in promoting the progress of atrophic gastritis and affected the level of serum gastric function. The study indicated that the eradication of <jats:italic>H. pylori<\/jats:italic> should be treated individually.<\/jats:p>","DOI":"10.1038\/s41598-021-83647-6","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:14:59Z","timestamp":1613812499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis"],"prefix":"10.1038","volume":"11","author":[{"given":"Weidong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiang","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"83647_CR1","doi-asserted-by":"crossref","unstructured":"Witkowska, M., Smolewski, P. Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma. Mediators Inflamm. 523170, 1\u20138 (2013).","DOI":"10.1155\/2013\/523170"},{"issue":"6","key":"83647_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.dld.2004.12.012","volume":"37","author":"K Miyake","year":"2005","unstructured":"Miyake, K. et al. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection. Dig. Liver Dis. 37(6), 394\u2013401 (2005).","journal-title":"Dig. Liver Dis."},{"key":"83647_CR3","doi-asserted-by":"crossref","unstructured":"Muzaheed. Helicobacter pylori oncogenicity: Mechanism, prevention, and risk factors. Sci. World J. 3018326, 1\u201310 (2020).","DOI":"10.1155\/2020\/3018326"},{"issue":"1","key":"83647_CR4","doi-asserted-by":"publisher","first-page":"e01869-15","DOI":"10.1128\/mBio.01869-15","volume":"7","author":"L Timothy","year":"2016","unstructured":"Timothy, L. Cover: Helicobacter pylori diversity and gastric cancer risk. mBio 7(1), e01869-15 (2016).","journal-title":"mBio"},{"issue":"11","key":"83647_CR5","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.1007\/s11033-014-3610-y","volume":"41","author":"BB Zhang","year":"2014","unstructured":"Zhang, B. B. et al. Association between vacA genotypes and the risk of duodenal ulcer: a meta-analysis. Mol. Biol. Rep. 41(11), 7241\u20137254 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"83647_CR6","doi-asserted-by":"publisher","first-page":"104167","DOI":"10.1016\/j.meegid.2019.104167","volume":"79","author":"SZ Bakhti","year":"2020","unstructured":"Bakhti, S. Z. et al. Unique constellations of five polymorphic sites of Helicobacter pylori vac A and cag A status associated with risk of gastric cancer. Infect. Genet. Evol. 79, 104167 (2020).","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"83647_CR7","doi-asserted-by":"publisher","first-page":"17616","DOI":"10.1038\/s41598-018-35937-9","volume":"8","author":"K Muhsen","year":"2018","unstructured":"Muhsen, K. et al. Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults. Sci. Rep. 8(1), 17616 (2018).","journal-title":"Sci. Rep."},{"issue":"3","key":"83647_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/apt.14424","volume":"47","author":"YJ Hwang","year":"2018","unstructured":"Hwang, Y. J. et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication\u2014A prospective study for up to 10 years[J]. Aliment Pharmacol. Ther. 47(3), 380\u2013390 (2018).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"1","key":"83647_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.15403\/jgld.2014.1121.271.pep","volume":"27","author":"O Sjomina","year":"2018","unstructured":"Sjomina, O. et al. Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: A population-based study. J. Gastrointestin. Liver Dis. 27(1), 11\u201317 (2018).","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"20","key":"83647_CR10","doi-asserted-by":"publisher","first-page":"e10820","DOI":"10.1097\/MD.0000000000010820","volume":"97","author":"W Su","year":"2018","unstructured":"Su, W. et al. Low PG I\/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. Medicine (Baltimore) 97(20), e10820 (2018).","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"83647_CR11","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4103\/0366-6999.231512","volume":"131","author":"XZ Chen","year":"2018","unstructured":"Chen, X. Z. et al. Gastric cancer screening by combined determination of serum Helicobacter pylori antibody and pepsinogen concentrations: ABC method for gastric cancer screening. Chin. Med. J. (Engl.) 131(10), 1232\u20131239 (2018).","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"6","key":"83647_CR12","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.7314\/APJCP.2013.14.6.3931","volume":"14","author":"A Shafaghi","year":"2013","unstructured":"Shafaghi, A. et al. Serum gastrin and the pepsinogen I\/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac. J. Cancer Prev. 14(6), 3931\u20133936 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"83647_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17474124.2020.1718491","volume":"14","author":"B Annibale","year":"2020","unstructured":"Annibale, B., Esposito, G. & Lahner, E. A current clinical overview of atrophic gastritis. Exp. Rev. Gastroenterol. Hepatol. 14(2), 93\u2013102 (2020).","journal-title":"Exp. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"83647_CR14","first-page":"721","volume":"37","author":"Chinese Society Of Gastroenterology","year":"2017","unstructured":"Chinese Society Of Gastroenterology. Chinese consensus on chronic gastritis (Shanghai, 2017). Chin. J. Digest. 37(11), 721\u2013738 (2017).","journal-title":"Chin. J. Digest."},{"key":"83647_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijmm.2010.06.006","volume":"301","author":"E Lahner","year":"2011","unstructured":"Lahner, E. et al. Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer. Int. J. Med. Microbiol. 301, 125\u2013132 (2011).","journal-title":"Int. J. Med. Microbiol."},{"issue":"2","key":"83647_CR16","doi-asserted-by":"publisher","first-page":"e12475","DOI":"10.1111\/hel.12475","volume":"23","author":"WZ Liu","year":"2018","unstructured":"Liu, W. Z. et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter 23(2), e12475 (2018).","journal-title":"Helicobacter"},{"issue":"11","key":"83647_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.dld.2015.06.010","volume":"47","author":"RM Zagari","year":"2015","unstructured":"Zagari, R. M. et al. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. Dig. Liver Dis. 47(11), 903\u2013912 (2015).","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"83647_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","volume":"15","author":"CA Fallone","year":"2016","unstructured":"Fallone, C. A. et al. The Toronto Consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 15(1), 51\u201369 (2016).","journal-title":"Gastroenterology"},{"key":"83647_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00535-011-0504-9","volume":"47","author":"M Kodama","year":"2012","unstructured":"Kodama, M. et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J. Gastroenterol. 47, 394\u2013403 (2012).","journal-title":"J. Gastroenterol."},{"issue":"9","key":"83647_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano, K. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64(9), 1353\u20131367 (2015).","journal-title":"Gut"},{"issue":"13","key":"83647_CR21","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.3748\/wjg.v22.i13.3670","volume":"22","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y. et al. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J. Gastroenterol. 22(13), 3670\u20133678 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"83647_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey, W. D. et al. ACG clinical guideline: Treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 112(2), 212\u2013239 (2017).","journal-title":"Am. J. Gastroenterol."},{"issue":"11 Suppl 7","key":"83647_CR23","first-page":"1","volume":"8","author":"AB Elfant","year":"2012","unstructured":"Elfant, A. B., Howden, C. W. & Stollman, N. Contemporary diagnostic strategies for the detection of Helicobacter pylori infection. Gastroenterol. Hepatol. (NY) 8(11 Suppl 7), 1\u201316 (2012).","journal-title":"Gastroenterol. Hepatol. (NY)"},{"issue":"7","key":"83647_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/00365521.2018.1476909","volume":"53","author":"S Skrebinska","year":"2018","unstructured":"Skrebinska, S. et al. Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H. pylori in middle-aged Caucasian general population sample. Scand. J. Gastroenterol. 53(7), 777\u2013783 (2018).","journal-title":"Scand. J. Gastroenterol."},{"key":"83647_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.micpath.2018.04.018","volume":"119","author":"E Shafaie","year":"2018","unstructured":"Shafaie, E. et al. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis\u2014A simple and cost-efficient method. Microb. Pathog. 119, 137\u2013144 (2018).","journal-title":"Microb. Pathog."},{"issue":"1","key":"83647_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000265933","volume":"82","author":"Y Wada","year":"2010","unstructured":"Wada, Y. et al. Relationship between Helicobacter pylori tyrosine-phosphorylated CagA-related markers and the development of diffuse-type gastric cancers: A case\u2013control study. Digestion 82(1), 10\u201317 (2010).","journal-title":"Digestion"},{"issue":"4","key":"83647_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/jgh.13256","volume":"31","author":"E Abdi","year":"2016","unstructured":"Abdi, E. et al. Helicobacter pylori vacuolating cytotoxin genotypes and preneoplastic lesions or gastric cancer risk: A meta-analysis. J. Gastroenterol. Hepatol. 31(4), 734\u2013744 (2016).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"83647_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fcimb.2017.00417","volume":"7","author":"N Li","year":"2017","unstructured":"Li, N. et al. Helicobacter pylori CagA protein negatively regulates autophagy and promotes inflammatory response via c-Met-PI3K\/Akt-mTOR signaling pathway. Front. Cell Infect. Microbiol. 7, 417 (2017).","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"4","key":"83647_CR29","doi-asserted-by":"publisher","first-page":"e01168","DOI":"10.1128\/mBio.01168-17","volume":"8","author":"A Gall","year":"2017","unstructured":"Gall, A. et al. TIFA signaling in gastric epithelial cells initiates the cag type 4 secretion system-dependent innate immune response to Helicobacter pylori infection. Mbio 8(4), e01168-e1217 (2017).","journal-title":"Mbio"},{"issue":"Pt A","key":"83647_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canep.2017.08.002","volume":"50","author":"NF de Larrea-Baz","year":"2017","unstructured":"de Larrea-Baz, N. F. et al. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case\u2013control study. Cancer Epidemiol. 50(Pt A), 76\u201384 (2017).","journal-title":"Cancer Epidemiol."},{"issue":"25","key":"83647_CR31","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.3748\/wjg.v26.i25.3673","volume":"26","author":"L Yuan","year":"2020","unstructured":"Yuan, L. et al. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J. Gastroenterol. 26(25), 3673\u20133685 (2020).","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"83647_CR32","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ijc.28560","volume":"134","author":"KF Pan","year":"2014","unstructured":"Pan, K. F. et al. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. Int. J. Cancer 134(9), 2118\u20132125 (2014).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"83647_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/proteomes5040024","volume":"5","author":"A Filomena","year":"2017","unstructured":"Filomena, A. et al. Performance of a multiplex serological Helicobacter pylori assay on a novel microfluidic assay platform. Proteomes 5(4), 24 (2017).","journal-title":"Proteomes"},{"key":"83647_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1099\/jmm.0.000049","volume":"64","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Analysis of the relationship between invasive capability of Helicobacter pylori and gastroduodenal diseases. J. Med. Microbiol. 64, 498\u2013506 (2015).","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"83647_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11655-017-2958-y","volume":"26","author":"HF Jin","year":"2017","unstructured":"Jin, H.F., Dai, J.F., Meng, L.N., Lu, B. Curcuma wenyujin Y. H. Chen et C. Ling n-Butyl alcohol extract inhibits AGS cell Helicobacter pylori CagA+ VacA+ promoted invasiveness by down-regulating caudal type homeobox transcription factor and claudin-2 expression. Chin. J. Integr. Med. 26(2), 122\u2013129 (2017).","journal-title":"Chin. J. Integr. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83647-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:54:43Z","timestamp":1670039683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83647-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83647"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83647-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"25 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4143"}}